Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2NET 1Endocrine 1

Conditions

Breast Neoplasms 168Neoplasms 132Prostatic Neoplasms 71Lung Neoplasms 67Colorectal Neoplasms 65Motor Activity 39Uterine Cervical Neoplasms 36Pancreatic Neoplasms 30Ovarian Neoplasms 27Head and Neck Neoplasms 27Brain Neoplasms 25Carcinoma, Non-Small-Cell Lung 23Rectal Neoplasms 21Glioblastoma 20Colonic Neoplasms 20Carcinoma, Hepatocellular 20Stomach Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Disease 16Depression 16Anxiety Disorders 16Hematologic Neoplasms 15Melanoma 14Leukemia 14Papillomavirus Infections 13Squamous Cell Carcinoma of Head and Neck 12Multiple Myeloma 12Glioma 12Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neoplasms, Glandular and Epithelial × 30 days × Clear all
NCT07377487 2026-05-22

INDIGO

Boston Scientific Corporation

Phase NA Recruiting
51 enrolled
EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06794073 2026-05-11

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Shanghai Zhongshan Hospital

Phase NA Recruiting
17 enrolled
Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡